The NIDA Animal Genomics Program aims to identify genetic variants influencing addictive behaviors, SUD stages, associated behaviors, and comorbidities through genomics approaches.
This grant supports early stage investigators proposing innovative, high-risk research on the biological and behavioral mechanisms underlying substance use disorders.
NIDA seeks to support shared drug-development infrastructure to help academic and biotech researchers repurpose medications for substance use disorders and advance them toward clinical development.
Supports collaborative research to map neural ensembles responding to addictive substances and build a multimodal database linking their activity to substance use behaviors; clinical trials are not allowed.
NIH supports exploratory, phased clinical research on the neurobiological mechanisms of substance use disorders, including relevant circuitry and behavior; clinical trials are optional.
This grant supports research using advanced single cell techniques to study how substance use disorders and HIV interact in the brain, aiming to uncover mechanisms and identify new therapy targets.